Ligand Announces Positive Preclinical Data on Small-Molecule GCSF Receptor Agonist at the 53rd Annual Meeting of the American Society of Hematology December 12, 2011
Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn® October 10, 2011
Ligand Partner GlaxoSmithKline Receives Positive Data from Promacta(R) PIII ENABLE1 Study in Hepatitis C-Related Thrombocytopenia July 26, 2011
Ligand to Advance Clinical Development of Captisol-enabled(R), Propylene Glycol-Free Melphalan for Multiple Myeloma June 22, 2011
Ligand Presents Phase IIa Data on Captisol(R)-Enabled, Propylene Glycol-Free Melphalan at ASCO 2011 June 6, 2011